Adage Capital Partners
TECH icon

Adage Capital Partners’s Bio-Techne TECH Stock Holding History

Adage Capital Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.5M Buy
389,500
+321,900
+476% +$17.4M 0.04% 414
2026
Q1 		$3.53M Sell
67,600
-305,636
-82% -$18.3M 0.01% 801
2025
Q4 		$22M Buy
373,236
+230,536
+162% +$14M 0.03% 454
2025
Q3 		$7.94M Sell
142,700
-125,900
-47% -$6.74M 0.01% 673
2025
Q2 		$13.8M Sell
268,600
-25,700
-9% -$1.29M 0.02% 537
2025
Q1 		$17.3M Sell
294,300
-204,200
-41% -$13.8M 0.03% 456
2024
Q4 		$35.9M Buy
498,500
+175,000
+54% +$12.9M 0.06% 284
2024
Q3 		$25.9M Buy
+323,500
New +$24.3M 0.05% 385
2024
Q1 		– Sell
-353,600
Closed -$27.3M – 947
2023
Q4 		$27.3M Buy
353,600
+197,100
+126% +$13M 0.06% 341
2023
Q3 		$10.7M Sell
156,500
-400
-0.3% -$31.6K 0.02% 548
2023
Q2 		$12.8M Buy
156,900
+74,400
+90% +$5.98M 0.03% 519
2023
Q1 		$6.12M Sell
82,500
-17,200
-17% -$1.33M 0.01% 683
2022
Q4 		$8.26M Sell
99,700
-60,300
-38% -$4.79M 0.02% 678
2022
Q3 		$11.4M Sell
160,000
-3,600
-2% -$311K 0.03% 603
2022
Q2 		$14.2M Sell
163,600
-400
-0.2% -$37.5K 0.03% 572
2022
Q1 		$17.8M Sell
164,000
-3,600
-2% -$371K 0.03% 509
2021
Q4 		$21.7M Hold
167,600
– – 0.04% 439
2021
Q3 		$20.3M Buy
+167,600
New +$20.4M 0.04% 445
2017
Q4 		– Sell
-240,000
Closed -$7.25M – 746
2017
Q3 		$7.25M Buy
+240,000
New +$7.12M 0.02% 597
2014
Q4 		– Sell
-201,064
Closed -$4.7M – 764
2014
Q3 		$4.7M Buy
+201,064
New +$4.71M 0.01% 621

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Adage Capital Partners's TECH Position: Q2 2026 in Review

Adage Capital Partners increased its Bio-Techne (TECH) stake by 476% in Q2 2026, buying an estimated $17.4M and bringing the position to 389,500 shares worth $27.5M. The position accounts for 0.04% of the portfolio, ranked #414.

Adage Capital Partners first reported a position in TECH in Q3 2014 and has held it in 20 quarters since. The position peaked at $35.9M in Q4 2024. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Adage Capital Partners held 389,500 shares of Bio-Techne worth $27.5M as of Q2 2026.
  • Adage Capital Partners bought 321,900 Bio-Techne shares in Q2 2026, an estimated $17.4M.
  • Bio-Techne made up 0.04% of Adage Capital Partners's portfolio in Q2 2026, its #414 holding.
  • Adage Capital Partners first reported a position in Bio-Techne in Q3 2014 and has held it in 20 quarters since.
  • Adage Capital Partners's Bio-Techne position peaked at $35.9M in Q4 2024.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.